252 related articles for article (PubMed ID: 11313687)
1. Infectious complications after high-dose chemotherapy and autologous stem cell transplantation: comparison between patients with lymphoma or multiple myeloma and patients with solid tumors.
Reich G; Mapara MY; Reichardt P; Dörken B; Maschmeyer G
Bone Marrow Transplant; 2001 Mar; 27(5):525-9. PubMed ID: 11313687
[TBL] [Abstract][Full Text] [Related]
2. Infectious complications after autologous hematopoietic stem cell transplantation: comparison of patients with acute myeloid leukemia, malignant lymphoma, and multiple myeloma.
Auner HW; Sill H; Mulabecirovic A; Linkesch W; Krause R
Ann Hematol; 2002 Jul; 81(7):374-7. PubMed ID: 12185506
[TBL] [Abstract][Full Text] [Related]
3. Infectious complication in 314 patients after high-dose therapy and autologous hematopoietic stem cell transplantation: risk factors analysis and outcome.
Gil L; Styczynski J; Komarnicki M
Infection; 2007 Dec; 35(6):421-7. PubMed ID: 17926001
[TBL] [Abstract][Full Text] [Related]
4. Infectious complications during neutropenia subsequent to peripheral blood stem cell transplantation.
Kolbe K; Domkin D; Derigs HG; Bhakdi S; Huber C; Aulitzky WE
Bone Marrow Transplant; 1997 Jan; 19(2):143-7. PubMed ID: 9116611
[TBL] [Abstract][Full Text] [Related]
5. Infectious complications after autologous peripheral blood progenitor cell transplantation followed by G-CSF.
Offidani M; Corvatta L; Olivieri A; Rupoli S; Frayfer J; Mele A; Manso E; Montanari M; Centurioni R; Leoni P
Bone Marrow Transplant; 1999 Nov; 24(10):1079-87. PubMed ID: 10578158
[TBL] [Abstract][Full Text] [Related]
6. Infectious complications in 126 patients treated with high-dose chemotherapy and autologous peripheral blood stem cell transplantation.
Salazar R; Solá C; Maroto P; Tabernero JM; Brunet J; Verger G; Valentí V; Cancelas JA; Ojeda B; Mendoza L; Rodríguez M; Montesinos J; López-López JJ
Bone Marrow Transplant; 1999 Jan; 23(1):27-33. PubMed ID: 10037047
[TBL] [Abstract][Full Text] [Related]
7. [Late infectious complications after high-dose therapy and autologous blood stem cell transplantation].
Metzner B; Grüneisl R; Gebauer W; Reschke D; Ost E; Müller TH; Reichert D; Rosien B; Del Valle F; Zirpel I; Kohse KP; Schunter F; Illiger HJ
Med Klin (Munich); 2002 Nov; 97(11):650-8. PubMed ID: 12434273
[TBL] [Abstract][Full Text] [Related]
8. Infections in patients managed at home during autologous stem cell transplantation for lymphoma and multiple myeloma.
Herrmann RP; Trent M; Cooney J; Cannell PK
Bone Marrow Transplant; 1999 Dec; 24(11):1213-7. PubMed ID: 10642811
[TBL] [Abstract][Full Text] [Related]
9. Infections during mobilizing chemotherapy and following autologous stem cell transplantation.
Toor AA; van Burik JA; Weisdorf DJ
Bone Marrow Transplant; 2001 Dec; 28(12):1129-34. PubMed ID: 11803354
[TBL] [Abstract][Full Text] [Related]
10. Prospective randomized comparative observation of single- versus split-dose lenograstim to enhance engraftment after autologous stem cell transplantation in patients with multiple myeloma or non-Hodgkin's lymphoma.
Jang G; Ko OB; Kim S; Lee DH; Huh J; Suh C
Transfusion; 2008 Apr; 48(4):640-6. PubMed ID: 18194384
[TBL] [Abstract][Full Text] [Related]
11. Iron overload is a major risk factor for severe infection after autologous stem cell transplantation: a study of 367 myeloma patients.
Miceli MH; Dong L; Grazziutti ML; Fassas A; Thertulien R; Van Rhee F; Barlogie B; Anaissie EJ
Bone Marrow Transplant; 2006 May; 37(9):857-64. PubMed ID: 16532017
[TBL] [Abstract][Full Text] [Related]
12. Incidence of Clostridium difficile-associated diarrhea before and after autologous peripheral blood stem cell transplantation for lymphoma and multiple myeloma.
Arango JI; Restrepo A; Schneider DL; Callander NS; Ochoa-Bayona JL; Restrepo MI; Bradshaw P; Patterson J; Freytes CO
Bone Marrow Transplant; 2006 Mar; 37(5):517-21. PubMed ID: 16435018
[TBL] [Abstract][Full Text] [Related]
13. Empirical antimicrobial monotherapy in patients after high-dose chemotherapy and autologous stem cell transplantation: a randomised, multicentre trial.
Reich G; Cornely OA; Sandherr M; Kubin T; Krause S; Einsele H; Thiel E; Bellaire T; Dörken B; Maschmeyer G
Br J Haematol; 2005 Jul; 130(2):265-70. PubMed ID: 16029455
[TBL] [Abstract][Full Text] [Related]
14. Continuous infusion of ceftazidime for patients with breast cancer and multiple myeloma receiving high-dose chemotherapy and peripheral blood stem cell transplantation.
Egerer G; Goldschmidt H; Hensel M; Harter C; Schneeweiss A; Ehrhard I; Bastert G; Ho AD
Bone Marrow Transplant; 2002 Oct; 30(7):427-31. PubMed ID: 12368954
[TBL] [Abstract][Full Text] [Related]
15. Oral mucositis and outcomes of autologous hematopoietic stem-cell transplantation following high-dose melphalan conditioning for multiple myeloma.
Vera-Llonch M; Oster G; Ford CM; Lu J; Sonis S
J Support Oncol; 2007 May; 5(5):231-5. PubMed ID: 17564153
[TBL] [Abstract][Full Text] [Related]
16. Autologous peripheral blood stem cell transplantation in the patients with hematologic malignancies and solid tumors.
Ke X; Yang Y; Zhao X; Wang L
Chin Med J (Engl); 2001 Feb; 114(2):196-9. PubMed ID: 11780206
[TBL] [Abstract][Full Text] [Related]
17. Correlation of residual leukocyte subsets with neutropenic fever during severe leukopenia after high-dose chemotherapy and autologous stem cell transplantation.
Schnabel B; Schmidmaier R; Franke D; Emmerich B; Straka C
Cytotherapy; 2006; 8(5):473-9. PubMed ID: 17050252
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcome of autologous stem cell transplantation in light chain deposition disease.
Lorenz EC; Gertz MA; Fervenza FC; Dispenzieri A; Lacy MQ; Hayman SR; Gastineau DA; Leung N
Nephrol Dial Transplant; 2008 Jun; 23(6):2052-7. PubMed ID: 18178602
[TBL] [Abstract][Full Text] [Related]
19. Autologous stem-cell transplantation restores the functional properties of CD14+CD16+ monocytes in patients with myeloma and lymphoma.
Dayyani F; Joeinig A; Ziegler-Heitbrock L; Schmidmaier R; Straka C; Emmerich B; Meinhardt G
J Leukoc Biol; 2004 Feb; 75(2):207-13. PubMed ID: 14576364
[TBL] [Abstract][Full Text] [Related]
20. IgD multiple myeloma--a clinical profile and outcome with chemotherapy and autologous stem cell transplantation.
Wechalekar A; Amato D; Chen C; Keith Stewart A; Reece D
Ann Hematol; 2005 Feb; 84(2):115-7. PubMed ID: 15503021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]